Full Length Research Paper
References
|
Aguilar G, Delgado C, Corrales I, Izquierdo A, Gracia E, Moreno T, Romero E, Ferrando C, Carbonell JA, Borrás R, Navarro D (2015). Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study. BMC Res. Notes 8:491. |
|
|
Alp S, Arikan-Akdagli S, Gulmez D, Ascioglu S, Uzun O, Akova M (2015). Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010. Mycoses 58:498-505. |
|
|
Barchiesi F, Orsetti E, Gesuita R, Skrami E, Manso E (2016). Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014. Infection 44:205-2013. |
|
|
Barros AJD, Hirakata V (2003). Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med. Res. Methodol. 3:21. |
|
|
Berdal JE, Haagensen R, Ranheim T, Bjørnholt JV (2014). Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital. PLoS One 9:e103916. |
|
|
Caggiano G, Coretti C, Bartolomeo N, Lovero G, De Giglio O, Montagna MT (2015). Candida bloodstream infections in Italy: changing epidemiology during 16 years of surveillance. BioMed Res. Int. 2015:1-9. |
|
|
Colombo AL, Guimaraes T, Silva LR, de Almeida Monfardini LP, Cunha AK, Rady P, Alves T, Rosas RC (2007). Prospective observational study of candidemia in São Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality. Infect. Control Hosp. Epidemiol. 28:570-576. |
|
|
Colombo AL, Nucci M, et al. and for the Brazilian Network Candidemia Study (2006). Epidemiology of candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers. J. Clin. Microbiol. 44:2816-2823. |
|
|
Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L (2015). Epidemiology and outcome of fungemia in a cancer cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin. Infect. Dis. 61:324-331. |
|
|
Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M (2012). The changing epidemiology of healthcare-associated candidemia over three decades. Diagn. Microbiol. Infect. Dis. 73:45-48. |
|
|
Ding X, Yan D, Sun W, Zeng Z, Su R, Su J (2015). Epidemiology and risk factors for nosocomial Non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med. Mycol. 53: 684-690. |
|
|
Fisher BT, Vendetti N, Bryan M, Prasad PA, Localio AR, Damianos A, Coffin SE, Bell LM, Walsh TJ, Gross R, Zaoutis TE (2016). Central venous catheter retention and mortality in children with candidemia: a retrospective cohort analysis. J. Pediatr. Infect. Dis. Soc. 5(4):403-408 |
|
|
Glöckner A, Karthaus M (2011). Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients. Mycoses 54:420-433. |
|
|
Gonçalves SS, Amorim CS, Nucci M, Padovan ACB, Briones MRS, Melo ASA, Colombo AL (2010). Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin. Microbiol. Infect. 16:885-887. |
|
|
Guimarães T, Nucci M, Mendonça JS, Martinez R, Brito LR, Silva N, Moretti ML, Salomao R, Colombo AL (2012). Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int. J. Infect. Dis. 16:e442-e447. |
|
|
Heimann SM, Cornely OA, Wisplinghoff H, Kochanek M, Stippel D, Padosch SA, Langebartels G, Reuter H, Reiner M, Vierzig A, Seifert H (2015). Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 34:331-338. |
|
|
Hirano R, Sakamoto Y, Kudo K, Ohnishi M (2015). Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience. Infect. Drug Resist. 8:199-205. |
|
|
Hoffmann-Santos HD, Paula CR, Yamamoto AC, Tadano T, Hahn RC (2013). Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, Midwest Region of Brazil. Mycopathologia 176:409-415. |
|
|
Imran ZK, Alshammry ZW (2016). Molecular diagnosis of Candidemia of intensive care unite patients based on sequencing analysis of ITS regions. Int. J. PharmTech Res. 9(12):658-668. |
|
|
Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N (2013). Emergence of non-albicans Candida species in neonatal candidemia. N. Am. J. Med. Sci. 5:541-545. |
|
|
Krcmery V, Barnes AJ (2002). Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260. |
|
|
Li C, Wang H, Yin M, Han H, Yue JF, Zhang F, Shan TC, Guo HP, Wu DW (2015). The differences in the epidemiology and predictors of death between candidemia acquired in intensive care units and other hospital settings. Intern. Med. 54:3009-3016. |
|
|
Lotfi N, Shokohi T, Nouranibaladezaei SZ, Nasrolahi Omran A, Kondori N (2015). High recovery rate of non-albicans Candida species isolated from burn patients with candidemia in Iran. Jundishapur J. Microbiol. 8:e22929. |
|
|
Mondelli AL, Niéro-Melo L, Bagagli E, Camargo CH, Bruder-Nascimento A, Sugizaki MF, Carneiro MV, Villas Boas PJ (2012). Candidemia in a Brazilian tertiary hospital: microbiological and clinical features over a six-year period. J. Venom. Anim. Toxins Incl. Trop. Dis. 18:244-252. |
|
|
Moran C, Grussemeyer CA, Spalding JR, Benjamin DK, Reed SD (2009). Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs. Pediatr. Infect. Dis. J. 28:433-435. |
|
|
Morii D, Seki M, Binongo JN, Ban R, Kobayashi A, Sata M, Hashimoto S, Shimizu J, Morita S, Tomono K (2014). Distribuition of Candida species isolated from blood cultures in hospitals in Osaka, Japan. J. Infect. Chemother. 20:558-562. |
|
|
Mu-oz P, Vena A, Valerio M, Álvarez-Uría A, Guinea J, Escribano P, Bouza E (2016). Risk factors for late recurrent candidemia. A retrospective matched case-control study. Clin. Microbiol. Infect. 22:e11-20. |
|
|
Ng KP, Kuan CS, Kaur H, Na SL, Atiya N, Velayuthan RD (2015). Candida species epidemiology 2000-2013: a laboratory-based report. Trop. Med. Int. Heath 20:1447-1453. |
|
|
Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, Guzman-Blanco M, Santolaya ME, Thompson L, Sifuentes-Osornio J, Echevarria JI (2013). Epidemiology of Candidemia in Latin America: a laboratory-based survey. PLoS One 8:e59373. |
|
|
Ortega M, Marco F, Soriano A, Almela M, Martínez JA, López J, Pitart C, Mensa J (2011). Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. J. Hosp. Infect. 77:157-161. |
|
|
Oud L (2016). Secular trends in utilization of critical care services among candidemia-associated hospitalizations: a population-based cohort study. J. Clin. Med. Res. 8:40-43. |
|
|
Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE (2014). Epidemiology and outcomes of invasive candidiasis due to non-albicans species of candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004–2008. PLoS One 9:e101510. |
|
|
Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D (2012). Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. Diagn. Microbiol. Infect. Dis. 74:323-331. |
|
|
Pinhati HMS, Casulari LA, Souza ACR, Siqueira RA, Damasceno CMG, Colombo AL (2016). Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit. BMC Infect. Dis. 16:433. |
|
|
Richet H, Roux P, Des Champs C, Esnault Y, Andremont A (2002). Candidemia in French hospitals: incidence rates and characteristics. Clin. Microbiol. Infect. 8: 405-412. |
|
|
Tortorano AM, Biraghi E, Astolfi AT, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A (2002). European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J. Hosp. Infect. 51:297-304. |
|
|
Wu JQ, Zhu LP, Ou XT, Xu B, Hu XP, Wang X, Weng XH (2011). Epidemiology and risk factors for non-Candida albicans candidemia in non-neutropenic patients at a Chinese teaching hospital. Med. Mycol. 49:552-555. |
|
|
Wu Z, Liu Y, Feng X, Liu Y, Wang S, Zhu X, Chen Q, Pan S (2014). Candidemia: incidence rates, type of species, and risk factors at a tertiary care academic hospital in China. Int. J. Infect. Dis. 22:4-8. |
|
|
Yapar N (2014). Epidemiology and risk factors for invasive candidiasis. Ther. Clin. Risk Manage. 10:95-105. |
|
|
Ziccardi M, Souza LO, Gandra RM, Galdino AC, Baptista AR, Nunes AP, Ribeiro MA, Branquinha MH, Santos AL (2015). Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes. Int. J. Med. Microbiol. 305:848-859. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
